ES478201A1 - Un procedimiento para la preparacion de ftalazinas. - Google Patents

Un procedimiento para la preparacion de ftalazinas.

Info

Publication number
ES478201A1
ES478201A1 ES478201A ES478201A ES478201A1 ES 478201 A1 ES478201 A1 ES 478201A1 ES 478201 A ES478201 A ES 478201A ES 478201 A ES478201 A ES 478201A ES 478201 A1 ES478201 A1 ES 478201A1
Authority
ES
Spain
Prior art keywords
piperidinophthalazines
cardiac stimulants
stimulants
cardiac
piperidinophthalazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES478201A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp
Original Assignee
Pfizer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp filed Critical Pfizer Corp
Publication of ES478201A1 publication Critical patent/ES478201A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Procedimiento para la preparación de ftalazinas de fórmula **fórmula ** donde (i) R1 es un átomo de hidrógeno o un grupo alquilo inferior, (ii) (R2)n representa de 1 a 3 sustituyentes, siendo cada radical R2 un grupo hidroxi o alcoxi inferior y siendo n un número de 1 a 3 o bien dos cualesquiera de los radicales R2 constituyen un grupo metilendioxi o etilendioxi unido a posiciones adyacentes del anillo bencénico
ES478201A 1977-06-03 1979-03-01 Un procedimiento para la preparacion de ftalazinas. Expired ES478201A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2358277 1977-06-03

Publications (1)

Publication Number Publication Date
ES478201A1 true ES478201A1 (es) 1980-02-01

Family

ID=10198020

Family Applications (4)

Application Number Title Priority Date Filing Date
ES470470A Expired ES470470A1 (es) 1977-06-03 1978-06-02 Un procedimiento para la preparacion de ftalazinas
ES478200A Expired ES478200A1 (es) 1977-06-03 1979-03-01 Un procedimiento para la preparacion de ftalazinas.
ES478201A Expired ES478201A1 (es) 1977-06-03 1979-03-01 Un procedimiento para la preparacion de ftalazinas.
ES478199A Expired ES478199A1 (es) 1977-06-03 1979-03-01 Un procedimiento para la preparacion de etalazinas.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES470470A Expired ES470470A1 (es) 1977-06-03 1978-06-02 Un procedimiento para la preparacion de ftalazinas
ES478200A Expired ES478200A1 (es) 1977-06-03 1979-03-01 Un procedimiento para la preparacion de ftalazinas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES478199A Expired ES478199A1 (es) 1977-06-03 1979-03-01 Un procedimiento para la preparacion de etalazinas.

Country Status (29)

Country Link
US (1) US4289772A (es)
JP (1) JPS5416488A (es)
AR (2) AR222013A1 (es)
AT (2) AT362792B (es)
AU (1) AU505373B1 (es)
BE (1) BE867727A (es)
CA (1) CA1111850A (es)
DD (1) DD137355A5 (es)
DE (1) DE2824064A1 (es)
DK (1) DK248078A (es)
EG (1) EG13527A (es)
ES (4) ES470470A1 (es)
FI (1) FI781753A (es)
FR (1) FR2392986A1 (es)
GB (1) GB2000136B (es)
GR (1) GR74402B (es)
HU (1) HU179745B (es)
IL (1) IL54842A (es)
IN (3) IN148482B (es)
IT (1) IT1094944B (es)
LU (1) LU79761A1 (es)
NL (1) NL7806016A (es)
NO (1) NO781935L (es)
NZ (1) NZ187453A (es)
PL (3) PL113208B1 (es)
PT (1) PT68126A (es)
SE (1) SE7806519L (es)
SU (2) SU856383A3 (es)
ZA (1) ZA783183B (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370328A (en) * 1977-11-03 1983-01-25 Pfizer Inc. Cardiac stimulant 1-(3- or 4-substituted piperidino)phthalazines
IL59619A0 (en) * 1979-03-28 1980-06-30 Pfizer Phthalazine derivatives,their preparation and pharmaceutical compositions containing them
PH17019A (en) * 1980-03-01 1984-05-11 Wyeth John & Brother Ltd 4-piperidyl-or dehydropiperidyl-urea derivatives and method of use
GB8320958D0 (en) * 1983-08-03 1983-09-07 Pfizer Ltd Quinazoline cardiac stimulants
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
US4882354A (en) * 1987-12-16 1989-11-21 Norwich Eaton Pharmaceuticals, Inc. N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents
JP3169188B2 (ja) * 1991-01-31 2001-05-21 杏林製薬株式会社 カルバミン酸誘導体及びその製造方法
US5300515A (en) * 1991-01-31 1994-04-05 Kyorin Pharmaceutical Co., Ltd. Carbamic acid derivatives and method for preparing the same
EP0621267A1 (en) * 1993-04-07 1994-10-26 Shell Internationale Researchmaatschappij B.V. Spiropiperidine derivatives and their use as fungicides
AU5772196A (en) * 1995-05-19 1996-11-29 Chiroscience Limited 3,4-disubstituted-phenylsulphonamides and their therapeutic use
CN1121220C (zh) * 1996-08-20 2003-09-17 卫材株式会社 稠合哒嗪系化合物的勃起机能不全症治疗剂
US20030186963A1 (en) 2001-09-14 2003-10-02 Dorwald Florencio Zaragoza Substituted piperidines
US20040224986A1 (en) * 2002-08-16 2004-11-11 Bart De Corte Piperidinyl targeting compounds that selectively bind integrins
AU2003259891A1 (en) * 2002-08-16 2004-03-19 Janssen Pharmaceutica N.V. Piperidinyl compounds that selectively bind integrins
US20060019975A1 (en) * 2004-07-23 2006-01-26 Pfizer Inc Novel piperidyl derivatives of quinazoline and isoquinoline
TW200630337A (en) 2004-10-14 2006-09-01 Euro Celtique Sa Piperidinyl compounds and the use thereof
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
BRPI0707223A2 (pt) * 2006-01-27 2011-04-26 Pfizer Prod Inc compostos de derivados de aminoftalazina
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007110449A1 (en) 2006-03-29 2007-10-04 Euro-Celtique S.A. Benzenesulfonamide compounds and their use
WO2007118854A1 (en) 2006-04-13 2007-10-25 Euro-Celtique S.A. Benzenesulfonamide compounds and the use thereof
WO2007118853A1 (en) 2006-04-13 2007-10-25 Euro-Celtique S.A. Benzenesulfonamide compounds and their use as blockers of calcium channels
JP2009536667A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド ５ｈｔ受容体介在性の神経新生
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
EP1900731A1 (de) * 2006-09-07 2008-03-19 Bayer Schering Pharma Aktiengesellschaft N-(1-Phthalazin-1-yl-piperidin-4-yl)-amide als EP2-Rezeptor Modulatoren
EP1903037A1 (de) * 2006-09-07 2008-03-26 Bayer Schering Pharma Aktiengesellschaft 1-(Het)aryl-3-[hetaryl-piperidin-4-yl]-thioharnstoffe als Modulatoren des EP2-Rezeptors
US7998971B2 (en) 2006-09-08 2011-08-16 Braincells Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US8399486B2 (en) 2007-04-09 2013-03-19 Purdue Pharma L.P. Benzenesulfonyl compounds and the use thereof
JP2010535733A (ja) 2007-08-07 2010-11-25 エフ．ホフマン−ラ ロシュ アーゲー Ｎｋ３受容体アンタゴニストとしてのピロリジンアリールエーテル
JP2010536818A (ja) 2007-08-22 2010-12-02 エフ．ホフマン−ラ ロシュ アーゲー Ｎｋ３受容体アンタゴニストとしてのピロリジンアリール−エーテル
KR101174980B1 (ko) * 2007-09-14 2012-08-17 에프. 호프만-라 로슈 아게 Ｎｋ３ 수용체 길항제로서의 피페리딘 유도체
US8765736B2 (en) 2007-09-28 2014-07-01 Purdue Pharma L.P. Benzenesulfonamide compounds and the use thereof
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
AR077014A1 (es) * 2009-06-19 2011-07-27 Lilly Co Eli Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer
US20150119399A1 (en) 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
CN113087654B (zh) * 2021-04-15 2022-12-23 苏州昊帆生物股份有限公司 哌啶-4-丁胺的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1094044A (en) * 1965-07-12 1967-12-06 Vantorex Ltd Phthalazine derivatives
GB1199768A (en) 1966-10-31 1970-07-22 Pfizer & Co C Nitrogen Heterocycles and process for their preparation
GB1293565A (en) 1969-05-03 1972-10-18 Aspro Nicholas Ltd Aminophthalazines and pharmaceutical compositions thereof
GB1460389A (en) 1974-07-25 1977-01-06 Pfizer Ltd 4-substituted quinazoline cardiac stimulants

Also Published As

Publication number Publication date
LU79761A1 (fr) 1980-01-22
IN149550B (es) 1982-01-16
JPS5538351B2 (es) 1980-10-03
PT68126A (en) 1978-07-01
ES470470A1 (es) 1979-09-01
GR74402B (es) 1984-06-28
ATA400878A (de) 1980-11-15
JPS5416488A (en) 1979-02-07
NZ187453A (en) 1980-12-19
ZA783183B (en) 1979-06-27
HU179745B (en) 1982-12-28
IL54842A (en) 1982-01-31
FR2392986B1 (es) 1982-07-16
IT7824106A0 (it) 1978-06-01
PL116437B1 (en) 1981-06-30
SU856383A3 (ru) 1981-08-15
AT363096B (de) 1981-07-10
AT362792B (de) 1981-06-10
DD137355A5 (de) 1979-08-29
IT1094944B (it) 1985-08-10
ES478199A1 (es) 1980-01-16
IL54842A0 (en) 1978-08-31
BE867727A (fr) 1978-12-01
PL116420B1 (en) 1981-06-30
GB2000136A (en) 1979-01-04
AU505373B1 (en) 1979-11-15
NO781935L (no) 1978-12-05
IN149973B (es) 1982-06-19
PL207337A1 (pl) 1979-06-04
AR222013A1 (es) 1981-04-15
NL7806016A (nl) 1978-12-05
FI781753A (fi) 1978-12-04
EG13527A (en) 1981-12-31
GB2000136B (en) 1982-01-06
FR2392986A1 (fr) 1978-12-29
CA1111850A (en) 1981-11-03
AR223999A1 (es) 1981-10-15
SU862826A3 (ru) 1981-09-07
SE7806519L (sv) 1978-12-04
ES478200A1 (es) 1980-01-01
ATA305080A (de) 1980-12-15
US4289772A (en) 1981-09-15
PL113208B1 (en) 1980-11-29
DE2824064A1 (de) 1978-12-14
DK248078A (da) 1978-12-04
IN148482B (es) 1981-03-07

Similar Documents

Publication Publication Date Title
ES478200A1 (es) Un procedimiento para la preparacion de ftalazinas.
AU3905678A (en) Alph-halomethyl derivatives of amines
PH13955A (en) Novel heterocyclic derivatives of 1-(1,3-
JPS53137992A (en) Nnalkyllnnacyl derivative of thienamycine
AU517458B2 (en) Acetylenic derivatives of amines
GR64297B (en) Base of time
IL53795A0 (en) Derivatives of thio-methylcarbamates
ZA787399B (en) Medicine with activity as prostaglandin synthetase inhibitor
ZA783285B (en) New derivatives of amidinopenicillanic acid
AU514558B2 (en) Scale inhibitors
GB2002764B (en) Derivatives of n-substituted-2-aminobenzoic acid
JPS53101769A (en) Hydroocyclone of radial multiistage type
GB2001074B (en) Cyclized derivatives of n-n-phosphonomethylglycine comp.
AU514875B2 (en) 17-acetylene derivatives of androst-4-ene
GB2000129B (en) Hydrazono derivatives of penicillins
GB2002748B (en) Cardiac stimulants
IL54308A0 (en) Derivatives of 9-fluoroprednisolone
ZA782927B (en) Cardiac stimulants
EG13473A (en) Derivatives of oxanilic acid
JPS5414862A (en) Production of steel desk
PH13855A (en) New derivatives of hydrasinium phosphite
JO884B1 (en) Amidinoformic acid
JPS5452098A (en) Methoion derivatives of pyrazolotriazilopyrimidines
ZA781643B (en) Derivatives of 9-fluoroprednisolone
KR790000539Y1 (en) Leather of fish-skin